COVID-19 vaccine AZD1222 clinical trials resumed in the UK
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health ...
Read moreClinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health ...
Read moreCompany working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators New Brunswick, N.J., August 05, ...
Read moreJul 30, 2020 United States Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that ...
Read moreAgreement relates to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system Both companies are committed ...
Read moreApril 29, 2020 09:00 AM Eastern Daylight Time SACRAMENTO, Calif.--(BUSINESS WIRE)--Verndari, Inc., a biopharmaceutical company in Napa, California, announced today ...
Read more© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital
© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital